Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Benchmark Animal Health is a leading aquaculture biotechnology company specializing in health solutions for the global fish and shrimp farming industries. As a core division of Benchmark Holdings, the company develops and commercializes innovative vaccines, therapeutic treatments, and advanced water purification systems to improve animal welfare and environmental sustainability. Its flagship offerings include Ectosan Vet, a highly effective treatment for sea lice, and the CleanTreat system, which ensures medicinal residues are removed from treatment water before discharge. Benchmark operates globally with a strong focus on the salmon, shrimp, and tilapia markets, leveraging its expertise in genomics and immunology to combat major aquatic diseases. The company is recognized for its commitment to reducing the environmental impact of medicinal treatments in the aquaculture sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Benchmark Animal Health.